# FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

> **NCT07638371** · PHASE1 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 16 (estimated)

## Conditions studied

- Solid Tumor
- Solid Carcinoma
- Advanced Solid Tumor
- Unresectable Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **BIOLOGICAL:** MSK-TCR5

## Key facts

- **NCT ID:** NCT07638371
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-09
- **Primary completion:** 2030-06-09
- **Final completion:** 2030-06-09
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638371, "FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07638371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*